Integra Lifesciences Holdings Corp (STU:IL3)
€ 23.8 0.8 (3.48%) Market Cap: 1.83 Bil Enterprise Value: 3.43 Bil PE Ratio: 0 PB Ratio: 1.29 GF Score: 71/100

Q4 2021 Integra Lifesciences Holdings Corp Earnings Call Transcript

Feb 23, 2022 / 01:30PM GMT
Release Date Price: €56 (-2.61%)
Operator

Good day, and welcome to the Integra LifeSciences' Fourth Quarter 2021 Financial Results Call. Today's call is recorded. And I'd now like to turn the conference over to Chris Ward, Senior Director of Investor Relations. Please go ahead, sir.

Chris Ward

Thank you, Emma. Good morning, and thank you for joining the Integra LifeSciences' Fourth Quarter and Full Year 2021 Earnings Conference Call. Joining me on the call this morning are Jan De Witte, President and Chief Executive Officer; Glenn Coleman, Chief Operating Officer; and Carrie Anderson, Chief Financial Officer.

Earlier today, we issued a press release announcing our fourth quarter and full year 2021 financial results. Our corresponding earnings presentation, which will be referenced during the call is available at integralife.com under Investors and Events and Presentations.

Before we begin, I would like to remind you that statements made during this call may be considered forward looking. Factors that could cause actual results to differ materially are discussed in the company's Exchange Act

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot